KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Buildings (2016 - 2022)

Historic Buildings for Amgen (AMGN) over the last 14 years, with Q4 2022 value amounting to $4.2 billion.

  • Amgen's Buildings rose 429.49% to $4.2 billion in Q4 2022 from the same period last year, while for Dec 2022 it was $4.2 billion, marking a year-over-year increase of 429.49%. This contributed to the annual value of $4.2 billion for FY2022, which is 429.49% up from last year.
  • Per Amgen's latest filing, its Buildings stood at $4.2 billion for Q4 2022, which was up 429.49% from $4.0 billion recorded in Q4 2021.
  • Amgen's Buildings' 5-year high stood at $4.2 billion during Q4 2022, with a 5-year trough of $3.6 billion in Q4 2018.
  • For the 5-year period, Amgen's Buildings averaged around $3.9 billion, with its median value being $3.9 billion (2020).
  • In the last 5 years, Amgen's Buildings skyrocketed by 266.17% in 2020 and then soared by 443.35% in 2021.
  • Amgen's Buildings (Quarter) stood at $3.6 billion in 2018, then rose by 3.9% to $3.8 billion in 2019, then increased by 2.66% to $3.9 billion in 2020, then increased by 4.43% to $4.0 billion in 2021, then rose by 4.29% to $4.2 billion in 2022.
  • Its Buildings was $4.2 billion in Q4 2022, compared to $4.0 billion in Q4 2021 and $3.9 billion in Q4 2020.